Gregory Grunberg 89bio, Inc. (ETNB) insider trading activity

Gregory Grunberg is Director of 89bio, Inc.. Currently has a direct ownership of 0 shares of ETNB, which is worth approximately $0. The most recent transaction as insider was on Apr 21, 2021, when has been sold 850 shares (Common Stock) at a price of $27.6 per share, resulting in proceeds of $23,460. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Gregory Grunberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 21 2021	SELL Open market or private sale	$23,460 $27.6 p/Share	850 Reduced 100.0%	0 Common Stock
Nov 16 2020	BUY Other acquisition or disposition	-	850 Added 50.0%	850 Common Stock

Also insider at

KALA

Kala Pharmaceuticals, Inc. Healthcare